Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
bullish
Tonix Pharmaceuticals Holding
Watchlist
TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025
Equity Bottom-Up
349 Views
24 Feb 2025 19:00
Issuer-paid
On December 23, 2024, Tonix Pharmaceuticals Holding Corp. (TNXP) announced that the FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal...
What is covered in the Full Insight:
Business Update
PDUFA Date for TNX-102 SL
Financial Status
Clinical Trials and Market Potential
Risk Assessment
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 11-minute read)
Related Insights
More »
TNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia
TNXP: No AdCom Required for TNX-102 SL NDA
TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025
TNXP: NDA Filed for TNX-102 SL in Fibromyalgia
TNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization
Trending Collections
More »
Japan
Equity Bottom-Up
India
Philippines
Index Rebalance
Sell / Short Ideas
Event-Driven
South Korea
Unpaywalled Insights
Macroeconomics
Trending Insights
More »
HEW: Kicked Can Lands Steady
Korea Small Cap Gem #39: Messe ESANG
KOSPI Size Indices: Overlaps Between Active & Passive Flows
Anthem Biosciences IPO: FY25 In High Trajectory; Poised for Long-Term Growth; Attractive IPO Pricing
Johns Lyng (JLG AU): A PEP-Sponsored MBO
Top Unpaywalled Insights
More »
[IO Technicals 2025/28] Bullish Momentum Intensifies
De-Dollarisation Debate : Unmasking USD Over-Valuation
US Equities Hit All-Time Highs—but Are Markets Ignoring Growing Risks?
Why America's Manufacturing Dreams Might Be Economic Nightmares
Systematic Global Macro: Data, AI, and Models Are Reshaping Investing | New Barbarians AI Agent #05
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025
24 Feb 2025
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x